RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$190.74
-2.12 (-1.10%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+338.08%
YTD
+141.38%
Open$193.30
Previous Close$192.86
Day High$196.71
Day Low$189.05
52W High$224.31
52W Low$42.18
Volume—
Avg Volume1.52M
Market Cap42.21B
P/E Ratio—
EPS$-4.80
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$94.85
Above
SMA 200
$58.23
Above
RSI (14)
62.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-40.2% upside
Current
$190.74
$190.74
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.08 | -0.05% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.09 | -1.01% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.37 | -0.85% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $516.34 | +0.26% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $801.82 | -0.26% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.51 | -2.04% | 40.0 | 32.33B |